July 2019 Price Concessions – 1st update


July 2019 Price Concessions – 1st update

July 15, 2019

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack size Price Concession
Betahistine 8mg tablets 84 £1.37
Betahistine 16mg tablets 84 £2.50
Ibandronic acid 150mg tablets 1 £9.95
Losartan 12.5mg tablets 28 £3.82
Pantoprazole 40mg gastro-resistant tablets 28 £3.85
Prednisolone 5mg tablets 28 £2.25
Prednisolone sodium phosphate 0.5% ear/eye drops 10ml £2.49
Risedronate sodium 35mg tablets 4 £11.68
Tamoxifen 20mg tablets 30 £3.40
Tolbutamide 500mg tablets 28 £17.25
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 £8.90
Valsartan 160mg capsules 28 £14.99

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated June 2019 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

Posted in: ,

More Latest News >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...

PQS: NSAID quality criterion

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS)...